Market Research Logo

Thailand Pharmaceuticals and Healthcare Report Q2 2016

Thailand Pharmaceuticals and Healthcare Report Q2 2016

BMI View: Multinational drugmakers will continue to face a difficult business environment in Thailand. Designated as a 'Priority Watch List Country' for PhRMA's Special 301 submission for 2016, key issues highlighted in 2015 remain unaddressed. This includes low levels of intellectual property protection as well as a challenging procurement process that favours the Government Procurement Organization. Cost containment pressures will also become more acute as authorities seek to curb rising healthcare spending.

Headline Expenditure Projections

Pharmaceuticals: THB152bnbn (USD4.4bn) in 2015 to THB160bn (USD4.5bn) in 2016; +5.3% in local currency terms and +1.9% in US dollar terms.

Healthcare: THB614bn (USD17.9bn) in 2015 to THB655bn (USD18.5bn) in 2016: +6.7% in local currency and +-3.3% in US dollar terms.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Thailand 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Thailand 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Thailand 2012-2020)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Thailand 2012-2020)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Thailand 2012-2020)
Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Thailand 2012-2020)
Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Thailand 2012-2020)
Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Thailand 2012-2020)
OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Thailand 2012-2020)
Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Thailand 2014-2020)
Table: Pharmaceutical Trade Data And Forecasts local currency (Thailand 2014-2020)
Industry Risk/Reward Index
Asia Pacific Risk/Reward Index
Thailand Risk/Reward Index
Rewards
Risks
Regulatory Review
Intellectual Property Issues
Pricing Regime
Table: Price Build-Up Of Medicines In Thailand
Reimbursement Regime
Market Overview
Healthcare Sector
Table: Major Health Insurance Programmes In Thailand
Table: Healthcare Resources (Thailand 2010-2015)
Table: Healthcare Personnel (Thailand 2010-2015)
Table: Healthcare Activity (Thailand 2010-2015)
Research & Development
Clinical Trials
Epidemiology
Table: Estimated Number Of New Cases Of Cancer In Thailand
Competitive Landscape
Research-Based Industry
Table: PReMA Members
Table: Multinational Market Activity
Generic Drugmakers
Table: Pharmaceutical Manufacturers Of Modern Drugs, 2007-2012
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
Berlin Pharmaceutical Industry
Biolab
GlaxoSmithKline
Government Pharmaceutical Organisation
Merck & Co
Novartis
Pfizer
Sanofi
Demographic Forecast
Table: Population Headline Indicators (Thailand 1990-2025)
Table: Key Population Ratios (Thailand 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Thailand 1990-2025)
Table: Population By Age Group (Thailand 1990-2025)
Table: Population By Age Group % (Thailand 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report